Release date: 2009-04-15
Recently, the successful university in Taiwan announced the completion of the world's first mobile phone-sized early detection device for near-infrared breast cancer. It is expected to launch human trials in 2009 and mass production in 2010, so that women can also detect early in the home through this device. Breast cancer.
It is understood that the early detection device for near-infrared breast cancer developed by Chengda is based on the research results of Qian Baidun, a member of the National Academy of Sciences. Cheng Da said that Qian Baidun has developed a near-infrared breast cancer early detection device after more than ten years of research. The human body test has been completed in the United States, but the device is large and unlisted. Qian Baidun is a special professor of Chengda University and authorizes the research and development team of Chengda to carry out research on volume reduction. After two years of research success, the whole device can be reduced to the size of mobile phone and easy to carry.
According to Zeng Yonghua, the leader of the research and development team of Chengda, this mobile phone-sized near-infrared breast cancer early detection device does not need to invade the human body. It contains 5 to 7 wavelengths of near-infrared light source to scan the breast, and does not need to take off the clothes when scanning. And underwear. The detection device is equipped with a liquid crystal panel, and the detection result is displayed on the panel, and can be stored on the memory card. If there is any abnormality, the doctor can be provided as a reference for medical examination at the time of diagnosis. This device mainly provides women to self-test breasts at home, without having to go to the hospital for palpation by doctors, avoiding the situation. If self-detection finds abnormalities, it is necessary to go to the hospital for further precise examinations such as ultrasound. Zeng Yonghua said that the bio-optical technology of this device can be expanded to deeper lesion detection in the future, including brain oxygen, blood sugar, and even pancreatic cancer.
Breast cancer mainly occurs in women, accounting for the second place in female cancer mortality, second only to lung cancer. In general, breast cancer occurs mostly in women after the age of 40, but in recent years, the age group of breast cancer has a significant decline.
Shanghai Medical Device Industry Association
Natural Active Monomer, extracted from natural plant. we are a professional manufacturer and exporter of herbal/plant extract in China, we built a very good relationship with customers from UAS,Europe,Asia,South America etc. we provide professional before and after sales support for our customers,
Hot Products AS BELOW:
Berberine Hcl
Rutin
Amygdalin
Chlorogenic acid
Kaempferol
Caicalin
5-HTP
Resveratrol
Quercetin
Lycopene
Diosgenin
Chrysin
Natural Active Monomer
Natural Active Monomer,Plant Ingredients,Extract Powder,Rutin Extract
Excellent Health Products Co.,Ltd. , https://www.sino-excellent.com